Crossmark

Anti-apoptotic proteins BCL-2, MCL-1 and A1 summate collectively to maintain survival of immune cell populations both in vitro and in vivo

Crossref DOI link: https://doi.org/10.1038/cdd.2017.30

Published Online: 2017-03-31

Published Print: 2017-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Carrington, Emma M

Zhan, Yifan

Brady, Jamie L

Zhang, Jian-Guo

Sutherland, Robyn M

Anstee, Natasha S

Schenk, Robyn L

Vikstrom, Ingela B

Delconte, Rebecca B

Segal, David

Huntington, Nicholas D

Bouillet, Philippe

Tarlinton, David M

Huang, David CS

Strasser, Andreas

Cory, Suzanne

Herold, Marco J

Lew, Andrew M
License Information

Text and Data Mining valid from 2017-03-31
More Information

Article History

Received: 17 November 2016

Revised: 9 February 2017

Accepted: 10 February 2017

First Online: 31 March 2017

Competing interests

: All relevant authors are employees of The Walter and Eliza Hall Institute. This institute receives milestone payments for the development of BH3 mimetic drugs for therapy from Genentech and AbbVie.